FDA Approves First Generic Under-the-Tongue Suboxone

Share this content:
FDA Approves First Generic Under-the-Tongue Suboxone
FDA Approves First Generic Under-the-Tongue Suboxone

FRIDAY, June 15, 2018 (HealthDay News) -- The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and Drug Administration.

The generic version of Suboxone (buprenorphine and naloxone) film from Mylan Technologies Inc. and Dr. Reddy's Laboratories SA will be available in different strengths.

The brand name and generic films should be used as part of an overall treatment plan that includes counseling and psychosocial support, and may only be prescribed by Drug Addiction Treatment Act-certified prescribers, the FDA said.

Common side effects of these films include numbness, burning and inflammation in the mouth, headache, nausea, vomiting, excessive sweating, constipation, signs and symptoms of withdrawal, insomnia, pain, and peripheral edema.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »